Mangaluru CCB seizes Rs 1.58 crore MDMA; UAE pharmacies should audit controlled-drug workflows

Mangaluru City Crime Branch arrested three men and seized 1.79 kg of MDMA valued at about Rs 1.58 crore, a case that should prompt UAE healthcare operators to check how controlled-medicine risk is handled across pharmacies, clinics and insurance networks.

The direct event is in India, but the operating lesson is local. Dubai clinics licensed by the Dubai Health Authority (DHA), Abu Dhabi providers regulated by the Department of Health Abu Dhabi (DOH), and northern emirates facilities under the Ministry of Health and Prevention (MOHAP) all work in a market where controlled, semi-controlled and narcotic medicines require auditable custody. Synthetic-drug seizures also affect patient counselling, travel medicine, pharmacy due diligence and claims review.

What police reported in Mangaluru

Deccan Chronicle, citing Mangaluru police, reported that officers seized 1,796.96 grams of MDMA near DMart at Kumpala in Ullal taluk at around 10 pm on Thursday, 8 October 2026. The same report named the accused as Abdul Hafeel, 25, Zia-ul-Haq, 30, and Altaf, 28.

The Times of India reported that City Police Commissioner Sudheer Kumar Reddy CH said the drug had been procured from Amritsar, Punjab, concealed inside the water-storage compartment of a water purifier, and sent to Mangaluru by courier. Police also seized three mobile phones, one car, one autorickshaw, a courier box and the water purifier, with total seized property estimated at Rs 1.63 crore.

Why UAE operators should care

For Dubai pharmacy owners and COOs, the relevant point is auditability. DHA says its Drug Control section governs medication processes according to classifications approved by the Emirates Drug Establishment, including approvals for purchase, transfer, disposal, custody handover and narcotic-drug quota changes. DHA lists [email protected] for private healthcare facilities and professionals seeking those approvals through its Drug Control service page.

For Abu Dhabi providers, DOH has already set a date for digital inventory discipline. In circular 2024/112, DOH said the inventory management module of the national platform for prescribing and dispensing narcotic and controlled medicines was activated in Abu Dhabi from 15 July 2024. DOH told healthcare and pharmaceutical facilities, and pharmacists, to register and start using the platform, and said non-compliance would lead to disciplinary action under applicable laws.

For MOHAP-regulated pharmacies in Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, the practical issue is the named custodian. MOHAP’s service guide lists approval of the signature of the person responsible for narcotic-drug custody with a completion duration of 1 to 3 working days. The same guide says the service targets pharmacies within hospitals, one-day surgery centres and other eligible healthcare facilities.

• COOs should confirm the current controlled-drug custodian, handover record and double-check process after any pharmacist resignation or leave.
• CFOs should separate legitimate controlled-medicine claims from rejected or cash-paid drug-seeking episodes, since insurer reimbursement rules vary by policy.
• Medical directors should review prescribing privileges for controlled and semi-controlled medicines, especially in psychiatry, pain care, anaesthesia and emergency services.
• CIOs should confirm that pharmacy systems can retain prescription, stock, transfer and disposal records for inspection.

Patient and insurer exposure

The patient-facing risk is confusion between illegal synthetic drugs and lawful controlled medicines. The UAE’s federal narcotics framework permits dispensing of narcotic or psychotropic medicines only against a prescription issued by a licensed treating physician, with conditions set by the medical products and pharmacy law. Patients who travel with controlled medicines should check MOHAP rules before departure and carry the prescription, diagnosis letter and quantity record.

Insurers such as Sukoon in Dubai and Daman or Thiqa in Abu Dhabi are relevant when a patient tries to fill a controlled medicine through a network pharmacy. Coverage, co-pay and prior approval depend on the policy, diagnosis and prescriber. Patients should verify the formulary and network pharmacy in the insurer app or call centre before dispensing, since public price claims without a named medicine and dose are unreliable.

The operating response is simple: treat a foreign drug bust as a reminder to test the UAE chain of custody. Start with DHA requirements in Dubai, DOH platform use in Abu Dhabi and Al Ain, and MOHAP/EDE service requirements in the northern emirates. Then check whether each pharmacy location has a named custodian, active licence, current insurer network status and documented disposal route.

Patients and operators can cross-check licensed pharmacy providers in the UAE Open Healthcare Directory, which lists licensed healthcare providers across all seven emirates and includes pharmacy providers, contact details, accepted insurance plans, operating hours and directions.